Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1995 Apr;96(4):217-22.

[Adhesion molecules in leukocyte and endothelium interactions]

[Article in Slovak]
Affiliations
  • PMID: 7552386
Review

[Adhesion molecules in leukocyte and endothelium interactions]

[Article in Slovak]
M Horváthová. Bratisl Lek Listy. 1995 Apr.

Abstract

The subject of this survey are the leukocyte-endothelial cell interactions, which modulate leukocyte migration and vascular permeability. Understanding of the interaction processes play an important role in insights into the mechanisms of vascular injury. Adhesion molecules (ADM) of blood elements and endothelial cells are important in the leukocyte adhesion and transendothelial migration. Adhesion structures are divided into three major categories: selectins, integrins and members of the immunoglobulin superfamily. The bidirectional interactions between leukocytes and endothelial cells are influenced by cytokines. These protein mediators induce changes in the expression of adhesion receptor and may regulate the number and type of leukocytes that migrate from the blood into the inflamed tissues. Von Willebrand factor (vWf) is a suitable marker of endothelial cell injury, as a specific product of the endothelium. The role of vWf in the adhesion process is to form a molecular bridge between the platelet and the subendothelium of an injured vessel wall. ADM that participate in the immune reactions, represent a target of novel therapeutic approaches for the treatment of inflammatory and other diseases. (Fig. 1, Tab. 1, Ref. 43.)

PubMed Disclaimer

Similar articles

LinkOut - more resources